ReviewMaterials (Basel, Switzerland)2025
Advances in MXene Materials: Fabrication, Properties, and Applications.
Review in Materials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Synthesis and Surface Engineering of Two-Dimensional MXenes for Advanced Functional Applications.Chemical record (New York, N.Y.) · 2026Review
- Graphene-Based Sensors for Food Freshness Monitoring: Recent Advances, Performance, and Practical Challenges.Sensors (Basel, Switzerland) · 2026Review
- Phonon-Dominated In-Plane Thermal Conductivity of Single-Flake Metallic Ti3C2Tx MXene.Nano letters · 2026Article
- Engineering MXene Nanomaterials: Structure-Property Relationships, Functional Design, and Emerging Technologies.Nanomaterials (Basel, Switzerland) · 2026Review
- MXene-Based Piezoelectric and Triboelectric Energy Harvesters for Personalized Monitoring and Therapeutics.Small (Weinheim an der Bergstrasse, Germany) · 2026Review
- Recent Advances in Two-Dimensional Metallic MXenes as High-Performance Saturable Absorbers.Nanomaterials (Basel, Switzerland) · 2026Review
- Engineering MXenes: Tunable Mechanical Properties and Applications in Structural Systems.Materials (Basel, Switzerland) · 2026Review
- Unraveling the Potential of MXenes in Electrochemical Sensing: Mechanistic Insight, Design Principles, and Analytical Applications.Small science · 2026Review
- Nanocellulose Materials: Processing, Properties, and Application.Nanomaterials (Basel, Switzerland) · 2026Review
- MXene- and MOF-Based Hydrogels: Emerging Platforms for Electrochemical Biosensing and Health Monitoring.Micromachines · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This review provides a critical overview of MXenes, an innovative class of 2D transition metal carbides, nitrides, and carbonitrides, emphasizing their synthesis, properties, and application potential. We systematically examine synthesis methods, contrasting top-down approaches with emerging green alternatives and bottom-up techniques, evaluating each in terms of scalability, cost, and environmental impact. This paper highlights MXenes' unique characteristics, including high electrical conductivity, tunable surface chemistry, and structural versatility, which enable their use in energy storage, environmental remediation, biomedicine, and electromagnetic shielding. Key challenges such as oxidative instability, interfacial incompatibility, and hazardous etching processes are critically discussed. We identify future research priorities, including defect-engineered stabilization, AI-optimized manufacturing, and advanced integration protocols to bridge the gap between laboratory breakthroughs and industrial deployment. By integrating these insights, this review offers a roadmap for advancing MXenes from laboratory innovation to industrial application.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.